SURVIVAL OF PATIENTS WITH STAGE B2 COLON-CARCINOMA - THE GASTROINTESTINAL TUMOR STUDY-GROUP EXPERIENCE

被引：0
|
作者：
NAUTA, R
STABLEIN, DM
HOLYOKE, D
机构：
[1] EMMES CORP,11325 7 LOCKS RD,SUITE 214,POTOMAC,MD 20854
[2] GEORGETOWN UNIV,DEPT SURG,WASHINGTON,DC 20057
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT SURG ONCOL,BUFFALO,NY 14263
来源：
ARCHIVES OF SURGERY | 1989年 / 124卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：180 / 182
页数：3
相关论文
共 50 条
  • [21] Impact of mucinous histology on prognosis for patients with radically resected stage Dukes B2 and C colon cancer: Preliminary results
    Catalano, V.
    Loupakis, F.
    Bisonni, R.
    Torresi, U.
    Santini, D.
    Silva, R. R.
    Giustini, L.
    Falcone, A.
    D'Emidio, S.
    Rocchi, M.
    Graziano, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] INJECTION OF COLON-CARCINOMA PATIENTS WITH AUTOLOGOUS IRRADIATED TUMOR-CELLS AND FIBROBLASTS GENETICALLY-MODIFIED TO SECRETE INTERLEUKIN-2 (IL-2) - A PHASE-I STUDY
    SOBOL, RE
    ROYSTON, I
    FAKHRAI, H
    SHAWLER, DL
    CARSON, C
    DORIGO, O
    GJERSET, R
    GOLD, DP
    KOZIOL, J
    MERCOLA, D
    VANBEVEREN, C
    WILSON, D
    HUMAN GENE THERAPY, 1995, 6 (02) : 195 - 204
  • [23] INTERGROUP STUDY OF FLUOROURACIL PLUS LEVAMISOLE AS ADJUVANT THERAPY FOR STAGE-II DUKES B2 COLON-CANCER
    MOERTEL, CG
    FLEMING, TR
    MACDONALD, JS
    HALLER, DG
    LAURIE, JA
    TANGEN, CM
    UNGERLEIDER, JS
    EMERSON, WA
    TORMEY, DC
    GLICK, JH
    VEEDER, MH
    MAILLIARD, JA
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) : 2936 - 2943
  • [24] B-cell lymphoma 2 is associated with advanced tumor grade and clinical stage, and reduced overall survival in young Chinese patients with colorectal carcinoma
    Wang, Jiasheng
    He, Gan
    Yang, Qiang
    Bai, Lian
    Jian, Bin
    Li, Qugang
    Li, Zhongfu
    ONCOLOGY LETTERS, 2018, 15 (06) : 9009 - 9016
  • [25] A retrospective study of transarterial chemoembolization (TACE) combined with lenvatinib compared with TACE monotherapy for BCLC B2 stage hepatocellular carcinoma
    Liu, Junning
    Yan, Shu
    Zhang, Guangnian
    Yang, Linfeng
    Wei, Song
    Yi, Pengsheng
    ONCOLOGY LETTERS, 2023, 26 (06)
  • [26] ADJUVANT CONTINUOUS-INFUSION 5-FU, WHOLE-ABDOMINAL RADIATION, AND TUMOR BED BOOST IN HIGH-RISK STAGE-III COLON-CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP PILOT-STUDY
    FABIAN, C
    GIRI, S
    ESTES, N
    TANGEN, CM
    POPLIN, E
    VOGEL, S
    GOODWIN, W
    RIVKIN, S
    FLEMING, TR
    MACDONALD, JS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (02): : 457 - 464
  • [27] FACTORS THAT CONTRIBUTE TO INFERIOR SURVIVAL OF LOW-RISK STAGE 2B NEUROBLASTOMA PATIENTS: A CHILDREN'S ONCOLOGY GROUP STUDY
    Strother, Douglas R.
    London, Wendy B.
    Tagge, Edward
    Shimada, Hiroyuki
    Cohn, Susan L.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 995 - 995
  • [28] The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer
    Blum, Craig
    Graham, Amanda
    Yousefzadeh, Matt
    Shrout, Jessica
    Benjamin, Katie
    Krishna, Murli
    Hoda, Raza
    Hoda, Rana
    Cole, David J.
    Garrett-Mayer, Elizabeth
    Reed, Carolyn
    Wallace, Michael
    Mitas, Michael
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (03) : 579 - 584
  • [29] Prospective study of adjuvant therapy with monoclonal antibody 17-1A of Dukes' B2/B3-colon carcinoma -: Interim analysis of toxicity
    Queisser, W
    Franz, A
    Hartung, G
    Sturm, J
    Edler, L
    Bornbusch, D
    Dietrich, G
    Böllinger, C
    Gonnermann, M
    Wojatschek, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S70 - S70
  • [30] Prospective study of adjuvant therapy with monoclonal antibody 17-1A of Dukes' B2/B3 -: Colon carcinoma -: Interim analysis of toxicity
    Franz, A
    Queisser, W
    Hartung, G
    Sturm, J
    Edler, L
    Bornbusch, D
    Dietrich, G
    Böllinger, C
    Gonnermann, M
    Wojatschek, C
    Brauckhoff, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S55 - S55
12345